citalopram has been researched along with veratridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bendotti, C; Fumagalli, F; Prosperini, E; Rizzi, M; Samanin, R; Tarizzo, G | 1 |
| Artigas, F; Castañé, A; Gasull-Camós, J; Tarrés-Gatius, M | 1 |
2 other study(ies) available for citalopram and veratridine
| Article | Year |
|---|---|
Acute and chronic treatments with citalopram lower somatostatin levels in rat brain striatum through different mechanisms.
Topics: Animals; Blotting, Northern; Citalopram; Corpus Striatum; Dose-Response Relationship, Drug; Male; Nucleus Accumbens; Potassium Chloride; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Somatostatin; Tetrodotoxin; Veratridine | 1997 |
Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats.
Topics: Affect; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Citalopram; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Glutamic Acid; Kainic Acid; Limbic Lobe; Male; Neuroglia; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Quinoxalines; Raphe Nuclei; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Veratridine | 2017 |